EKF Diagnostics Holdings PLC Notice of GM (0678J)
June 26 2017 - 2:00AM
UK Regulatory
TIDMEKF
RNS Number : 0678J
EKF Diagnostics Holdings PLC
26 June 2017
EKF Diagnostics Holdings plc
("EKF", the "Company")
Notice of General Meeting
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical
diagnostics business, announces that a general meeting of the
Company will be held at the offices of Harwood Capital LLP, 6
Stratton Street, Mayfair, London W1J 8LD at 11:00 a.m. on 27(th)
July 2017 (the "General Meeting") for the purpose of considering
and, if thought fit, approving resolutions to cancel the share
premium reserve of the Company and to grant the Company the general
authority to make market purchases of its own shares.
The cancellation is necessary in order for the Company to
proceed with its previously announced share buyback plan of up to
15% of the Company's current issued share capital.
A copy of a circular containing the notice convening the General
Meeting and form of proxy will be posted to shareholders later
today and will shortly be available on the Company's website,
www.ekfdiagnostics.com in accordance with AIM Rule 20.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Tel: 029 2071 0570
Chairman
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Alex Price / Shaun Dobson
/ Ali Laughton-Scott
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOGOKNDQPBKDNAB
(END) Dow Jones Newswires
June 26, 2017 02:00 ET (06:00 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024